APP and early-onset autosomal dominant Alzheimer disease: Additionally, an in vivo study reported the use of a linear polyethyleneimine (LPEI)-g-polyethylene glycol (PEG) copolymer-based micellar nanoparticle system to deliver siRNA targeting BACE1 and APP, two key therapeutic targets in Alzheimer’s disease [122].